Results for tag: "Synthetic Small Molecule API"

The Synthetic Small Molecule API market is a subset of the pharmaceutical industry that focuses on the production of active pharmaceutical ingredients (APIs) through synthetic chemical processes. These APIs are used in the manufacture of drugs and other pharmaceutical products. The market is driven by the increasing demand for generic drugs, as well as the need for more cost-effective and efficient production of APIs. The market is also driven by the increasing demand for APIs in the development of new drugs and treatments. The Synthetic Small Molecule API market is highly competitive, with many companies offering a wide range of products and services. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include Teva Pharmaceuticals, Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more